AIM ImmunoTech shareholders approve reverse stock split and warrant/note conversion issuances

AIM ImmunoTech Inc.

Special meeting held July 15, 2026; quorum of 10,671,690 shares (38.5%) present.
Proposals 1-5 approved: issuance of >19.99% of shares upon exercise of Class H, I, J warrants and conversion of two promissory notes.
Proposal 6 approved: reverse stock split at ratio up to 1-for-25, ratio at Board discretion.
Proposal 7 approved: adjournment if needed to solicit additional proxies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.